Indian Journal of Science and Technology

Abstract

Immune deficiency is an important problem on HIV/AIDS patients. Traditional antidotes “Kallunk oxide”, a Complementary and Alternative Medicine (CAM), could be better restored the immunity in initial stage of HIV type-1 patients. The performed modest phase-1 study was observational, prospective and designs as open label, case- only, randomized, treatment, and efficacy research enrolled with CD3+ and CD4+ T cell counts >450, >250 and <200 cu/mm3 of 20 HIV/AIDS patients between the ages 8 and 55 years from both genders at the Project Site Office, HIRS, Palakkad- Dt, Kerala, India. The participants were received traditional antidotes “Kallunk oxide” treatment and the study includes Lymphocyte cell counts as assessed by Flow fluorescence cytometry analysis. The absolute CD3+ and CD4+ T cell numbers increased in four (4) HIV type-1 patients, as confirmed by the baseline CD4+ T cell counts above 450 cu/mm3 , showing above 50% increase after the CAM therapy. This traditional antidotes “Kallunk oxide” treatment boosts initial stage of HIV type-1 patients’ immunity.
Keywords: AIDS, Antidote, Kallunk oxide, HIV treatment, Siddha therapy, Traditional Indian Medicine